Osteoprotegerin (OPG), also known as osteoclastogenesis inhibitory factor (OCIF) or tumour necrosis factor receptor superfamily member 11B (TNFRSF11B)...
30 KB (3,687 words) - 20:28, 17 May 2024
member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is a protein...
28 KB (3,309 words) - 05:21, 5 August 2024
increased levels in patients at risk for cardiovascular disease. Also osteoprotegerin which involved with regulation of a key inflammatory transcription...
29 KB (3,354 words) - 03:24, 13 August 2024
to be RANKL dependent. Osteoclast differentiation is inhibited by osteoprotegerin (OPG), which is produced by osteoblasts and binds to RANKL thereby...
26 KB (2,925 words) - 20:28, 17 May 2024
increase their expression of RANKL and inhibits their secretion of osteoprotegerin (OPG). Free OPG competitively binds to RANKL as a decoy receptor, preventing...
34 KB (4,157 words) - 07:52, 21 May 2024
ligand (RANKL), also called osteoclast differentiation factor (ODF) and osteoprotegerin ligand (OPGL), is a regulator of osteoclast function. In physiological...
17 KB (1,818 words) - 04:48, 24 July 2024
rate at which osteoclasts resorb bone is inhibited by calcitonin and osteoprotegerin. Calcitonin is produced by parafollicular cells in the thyroid gland...
76 KB (8,829 words) - 02:50, 18 August 2024
OPG may refer to: Osteoprotegerin Office of the Public Guardian (disambiguation) Office of HM Paymaster General Online Policy Group Ontario Power Generation...
391 bytes (67 words) - 17:03, 15 March 2024
NF-κB. Osteoprotegerin (OPG), which is a decoy receptor homolog for RANK ligand (RANKL), inhibits RANK by binding to RANKL, and, thus, osteoprotegerin is...
89 KB (9,817 words) - 08:00, 10 June 2024
binding to and inhibiting RANKL. Denosumab mimics the natural action of osteoprotegerin, an endogenous RANKL inhibitor, that presents with decreasing concentrations...
26 KB (2,188 words) - 05:17, 13 June 2024
node development, thermal regulation, and mammary gland development. Osteoprotegerin (OPG) is a decoy receptor for RANKL, and regulates the stimulation...
23 KB (3,035 words) - 06:16, 25 December 2023
, Xu J, Wood DJ, Zheng MH (2000). "Gene Expression of Osteoprotegerin Ligand, Osteoprotegerin, and REceptor Activator of NF-kB in Giant Cell Tumor of...
14 KB (1,604 words) - 22:41, 29 February 2024
ultimately lead to the secretion of the RANK/RANKL inhibitor osteoprotegerin. Higher osteoprotegerin and IL-1β levels are a characteristic of breast cancer...
26 KB (3,305 words) - 17:31, 8 August 2024
lymphocytes), and stimulates RANK (receptor activator of nuclear factor κB). Osteoprotegerin (OPG) binds RANKL before it has an opportunity to bind to RANK, and...
124 KB (13,984 words) - 10:50, 13 August 2024
bloodstream. PTHrP also acts by activating rank ligand and inhibiting osteoprotegerin which activates nuclear factor kappa B, which causes further activation...
34 KB (3,298 words) - 19:13, 25 July 2024
chemokines Interleukin-8 and eotaxin-3, endothelin-1, angiopoietin-2, osteoprotegerin, the P-selectin cofactor CD63/lamp3, and α-1,3-fucosyltransferase VI...
9 KB (1,123 words) - 08:48, 28 May 2024
PMC 4117578. PMID 4117578. Lawrie A (December 2014). "The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the...
89 KB (8,902 words) - 09:54, 15 August 2024
calcium resorption from bone – and also inhibits the production of osteoprotegerin (OPG) which acts as a decoy receptor and captures some RANKL before...
78 KB (8,594 words) - 12:55, 16 August 2024
periodontal ligament undifferentiated mesenchymal cells. EMD also stimulates osteoprotegerin, serving to trigger osteoblasts and indirectly inhibit both osteoclastogenesis...
4 KB (535 words) - 16:22, 18 June 2022
member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF). RANKL affects...
96 KB (467 words) - 19:33, 6 August 2024
Fujikawa Y, Sabokbar A, Athanasou NA. (2000). The effect of osteoprotegerin and osteoprotegerin ligand on human arthroplasty macrophage-osteoclast differentiation...
9 KB (1,115 words) - 12:37, 6 August 2024
DR5 (TNFRSF10B) DcR1 (TNFRSF10C) DcR2 (TNFRSF10D) RANK (TNFRSF11A) Osteoprotegerin (TNFRSF11B) TweakR (TNFRSF12A) TACI (TNFRSF13B) BAFFR (TNFRSF13C) HVEM...
67 KB (7,845 words) - 11:20, 5 August 2024
formation. Strontium ranelate also stimulates osteoblasts to secrete osteoprotegerin in inhibiting osteoclasts formed from pre-osteoclasts in relation to...
16 KB (1,537 words) - 19:09, 12 May 2024
DR5 (TNFRSF10B) DcR1 (TNFRSF10C) DcR2 (TNFRSF10D) RANK (TNFRSF11A) Osteoprotegerin (TNFRSF11B) TweakR (TNFRSF12A) TACI (TNFRSF13B) BAFFR (TNFRSF13C) HVEM...
18 KB (1,937 words) - 21:50, 5 January 2024
DR5 (TNFRSF10B) DcR1 (TNFRSF10C) DcR2 (TNFRSF10D) RANK (TNFRSF11A) Osteoprotegerin (TNFRSF11B) TweakR (TNFRSF12A) TACI (TNFRSF13B) BAFFR (TNFRSF13C) HVEM...
35 KB (4,117 words) - 00:12, 6 August 2024
remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin". Int. J. Oncol. 43 (2): 365–74. doi:10.3892/ijo.2013.1954. PMC 3775580...
3 KB (493 words) - 18:32, 25 November 2023
DR5 (TNFRSF10B) DcR1 (TNFRSF10C) DcR2 (TNFRSF10D) RANK (TNFRSF11A) Osteoprotegerin (TNFRSF11B) TweakR (TNFRSF12A) TACI (TNFRSF13B) BAFFR (TNFRSF13C) HVEM...
6 KB (442 words) - 05:35, 18 May 2024
Nuclear factor kB ligand or osteoprotegerin pathway controls osteoclastogenesis. In the apex of the dental follicle, osteoprotegerin prevents osteoclast formation...
26 KB (3,475 words) - 22:41, 17 April 2024
TRAILR4, TRUNDD, CD264 TNFRSF10D 11 RANK (11A) CD265 TNFRSF11A RANKL Osteoprotegerin (11B) OCIF, TR1 TNFRSF11B 12 TWEAK receptor (12A) Fn14, CD266 TNFRSF12A...
8 KB (501 words) - 01:30, 27 December 2023
(Bisphosphonates) Commercial Biomedical Testing Module: Effects of Osteoprotegerin on Bone Maintenance in Microgravity (CBTM) Commercial Biomedical Test...
203 KB (14,125 words) - 15:59, 9 May 2024